These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 21459491

  • 1. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F.
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q, Holloway HW, Utsuki T, Brossi A, Greig NH.
    J Med Chem; 1999 May 20; 42(10):1855-61. PubMed ID: 10346939
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W, Li YP, He Y, Huang SL, Li D, Gu LQ, Huang ZS.
    Eur J Med Chem; 2011 Jun 20; 46(6):2609-16. PubMed ID: 21497959
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An Efficient Synthesis of bi-Aryl Pyrimidine Heterocycles: Potential New Drug Candidates to Treat Alzheimer's Disease.
    Rehman TU, Khan IU, Ashraf M, Tarazi H, Riaz S, Yar M.
    Arch Pharm (Weinheim); 2017 Apr 20; 350(3-4):. PubMed ID: 28220522
    [Abstract] [Full Text] [Related]

  • 9. Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation.
    Tonelli M, Catto M, Tasso B, Novelli F, Canu C, Iusco G, Pisani L, Stradis AD, Denora N, Sparatore A, Boido V, Carotti A, Sparatore F.
    ChemMedChem; 2015 Jun 20; 10(6):1040-53. PubMed ID: 25924599
    [Abstract] [Full Text] [Related]

  • 10. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
    Siwicka A, Moleda Z, Wojtasiewicz K, Zawadzka A, Maurin JK, Panasiewicz M, Pacuszka T, Czarnocki Z.
    J Pineal Res; 2008 Aug 20; 45(1):40-9. PubMed ID: 18284552
    [Abstract] [Full Text] [Related]

  • 11. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 20; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 12. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
    Razavi SF, Khoobi M, Nadri H, Sakhteman A, Moradi A, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2013 Jun 01; 64():252-9. PubMed ID: 23644208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W, Su YB, Hong C, Tian RG, Su LP, Wang YQ, Li Y, Yue JJ, Wang CJ.
    Bioorg Med Chem; 2013 Dec 01; 21(23):7275-82. PubMed ID: 24148835
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
    Saeed A, Mahesar PA, Zaib S, Khan MS, Matin A, Shahid M, Iqbal J.
    Eur J Med Chem; 2014 May 06; 78():43-53. PubMed ID: 24675179
    [Abstract] [Full Text] [Related]

  • 20. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS, Khan SU, Ejaz SA, Afridi S, Rizvi SUF, Najam-Ul-Haq M, Iqbal J.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):615-624. PubMed ID: 27865835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.